|
|
|
Insider
Information: |
Zulueta Alfonso G |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
228,617 |
|
Indirect Shares
|
4,667 |
|
|
Direct
Value |
$50,369,133 |
|
|
Indirect Value
|
$3,966,903 |
|
|
Total
Shares |
233,284 |
|
|
Total
Value |
$54,336,036 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
0
|
Stock
price went up :
|
5
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
5.0
|
0.0
|
Percentage
Gain/Loss : |
35.5%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
SVP & President, Lilly... |
2021-02-08 |
56,947 |
2021-02-08 |
4,667 |
Premium* |
|
CTS Corp |
CTS |
Director |
2023-11-02 |
30,013 |
2018-11-08 |
0 |
Premium* |
|
Syneos Health Inc |
SYNH |
Director |
2023-05-25 |
8,356 |
2022-01-18 |
0 |
Premium* |
|
First Light Acquisition Group, I... |
FLAG |
Director |
2023-12-21 |
133,301 |
2023-12-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
|
2017-02-01 |
4 |
D |
$77.03 |
$240,873 |
D/D |
(3,127) |
60,583 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
|
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,659 |
63,710 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP& Pres., Emerging Markets |
|
2017-02-06 |
4 |
S |
$77.66 |
$1,164,900 |
D/D |
(15,000) |
45,583 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2017-11-10 |
4 |
AS |
$83.67 |
$167,591 |
D/D |
(2,003) |
43,580 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2017-12-04 |
4 |
AS |
$86.00 |
$303,752 |
D/D |
(3,532) |
40,048 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2018-01-29 |
4 |
A |
$87.60 |
$816,082 |
D/D |
9,316 |
49,364 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2018-02-01 |
4 |
D |
$81.45 |
$580,983 |
D/D |
(7,133) |
58,224 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2018-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,993 |
65,357 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2018-09-17 |
4 |
AS |
$105.61 |
$316,830 |
D/D |
(3,000) |
55,224 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2018-09-18 |
4 |
AS |
$107.00 |
$321,000 |
D/D |
(3,000) |
52,224 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2018-10-04 |
4 |
AS |
$114.64 |
$802,480 |
D/D |
(7,000) |
45,224 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2019-01-31 |
4 |
AS |
$120.00 |
$480,000 |
D/D |
(4,000) |
41,224 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2019-02-01 |
4 |
D |
$119.86 |
$523,069 |
D/D |
(4,364) |
46,582 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2019-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,722 |
50,946 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2019-02-04 |
4 |
A |
$120.17 |
$2,550,488 |
D/D |
21,224 |
67,806 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2019-04-12 |
4 |
AS |
$124.65 |
$1,246,500 |
D/D |
(10,000) |
57,806 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2019-09-03 |
4 |
AS |
$112.91 |
$2,201,745 |
D/D |
(19,500) |
38,306 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2019-09-20 |
4 |
AS |
$117.00 |
$526,500 |
D/D |
(4,500) |
33,806 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2019-12-06 |
4 |
AS |
$120.00 |
$540,000 |
D/D |
(4,500) |
29,306 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2020-02-01 |
4 |
D |
$139.64 |
$1,019,232 |
D/D |
(7,299) |
38,324 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2020-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,317 |
45,623 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2020-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
18,322 |
56,646 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2020-06-05 |
4 |
AS |
$150.00 |
$1,500,000 |
D/D |
(10,000) |
46,646 |
0 |
% |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2020-06-16 |
4 |
AS |
$160.00 |
$2,770,000 |
D/D |
(17,000) |
29,646 |
0 |
% |
|
LLY |
Eli Lilly & Co |
SVP & President, Lilly Intl |
|
2021-02-01 |
4 |
D |
$207.97 |
$1,557,695 |
D/D |
(7,490) |
27,910 |
0 |
- |
|
56 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|